Newbridge Financial Services Group, Inc. Opiant Pharmaceuticals, Inc. Transaction History

Newbridge Financial Services Group, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 15, 2022	SELL	$10.12 - $23.32 $20,746 - $47,806	-2,050 Closed	0 $0
Q1 2022 Apr 26, 2022	BUY	$19.54 - $33.59 $3,908 - $6,718	200 Added 10.81%	2,050 $44,000
Q4 2021 Jan 19, 2022	SELL	$22.51 - $36.79 $6,753 - $11,037	-300 Reduced 13.95%	1,850 $62,000
Q3 2021 Oct 27, 2021	SELL	$13.28 - $25.79 $4,648 - $9,026	-350 Reduced 14.0%	2,150 $55,000
Q2 2021 Sep 07, 2021	SELL	$10.5 - $14.19 $29,400 - $39,732	-2,800 Reduced 52.83%	2,500 $33,000
Q1 2021 Sep 07, 2021	BUY	$8.2 - $14.49 $27,059 - $47,817	3,300 Added 165.0%	5,300 $56,000
Q4 2020 Sep 07, 2021	BUY	$6.87 - $8.88 $13,740 - $17,760	2,000 New	2,000 $16,000

300

Ticker OPNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 5,164,150
Description
Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overd...

Get notified when there are updates to the investment portfolio of Newbridge Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Newbridge Financial Services Group, Inc. with notifications on news.